We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIV
2476
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
$450K ﹤0.01%
16,080
-1,294
-7% -$36.2K
HIX
2477
Western Asset High Income Fund II
HIX
$355M
$448K ﹤0.01%
62,282
-3,946
-6% -$28.9K
P
2478
Everpure Inc
P
$29.9B
$448K ﹤0.01%
34,955
+12,355
+55% +$144K
AVP
2479
DELISTED
Avon Products, Inc.
AVP
$447K ﹤0.01%
117,510
+3,125
+3% +$12.2K
CSM icon
2480
ProShares Large Cap Core Plus
CSM
$534M
$446K ﹤0.01%
14,828
+2,940
+25% +$87.3K
VREX icon
2481
Varex Imaging
VREX
$523M
$446K ﹤0.01%
13,188
-5,750
-30% -$196K
POPE
2482
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$446K ﹤0.01%
6,022
-150
-2% -$10.8K
INST
2483
DELISTED
Instructure, Inc.
INST
$446K ﹤0.01%
15,104
-4,219
-22% -$107K
TGP
2484
DELISTED
Teekay LNG Partners L.P.
TGP
$444K ﹤0.01%
28,916
-5,039
-15% -$81.4K
FRO icon
2485
Frontline
FRO
$8.85B
$443K ﹤0.01%
77,344
-1,166
-1% -$7.16K
RARE icon
2486
Ultragenyx Pharmaceutical
RARE
$2.55B
$442K ﹤0.01%
7,110
+1,812
+34% +$109K
NMI icon
2487
Nuveen Municipal Income
NMI
$130M
$440K ﹤0.01%
37,505
-2,278
-6% -$27.6K
GHL
2488
DELISTED
Greenhill & Co., Inc.
GHL
$440K ﹤0.01%
21,910
+1,965
+10% +$46K
KRG icon
2489
Kite Realty
KRG
$5.36B
$439K ﹤0.01%
23,180
-11,133
-32% -$219K
CPRI icon
2490
Capri Holdings
CPRI
$1.74B
$438K ﹤0.01%
12,090
+794
+7% +$28.8K
CUTR
2491
DELISTED
Cutera, Inc.
CUTR
$438K ﹤0.01%
16,902
+400
+2% +$8.73K
RSPM icon
2492
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$194M
$435K ﹤0.01%
22,235
-29,115
-57% -$563K
RACE icon
2493
Ferrari
RACE
$72.5B
$434K ﹤0.01%
5,053
-277
-5% -$22.7K
MCHP icon
2494
CALL
Microchip Technology
MCHP
$46B
$432K ﹤0.01%
305,800
+100,400
+49% +$3.95M
WB icon
2495
Weibo
WB
$1.95B
$431K ﹤0.01%
6,487
-1,088
-14% -$70.6K
MQT
2496
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$430K ﹤0.01%
32,754
-8,150
-20% -$106K
TER icon
2497
Teradyne
TER
$59.3B
$430K ﹤0.01%
14,304
-12,980
-48% -$436K
INFY icon
2498
Infosys
INFY
$50.7B
$429K ﹤0.01%
57,068
-499,232
-90% -$3.74M
OEFA
2499
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$37.7M
$429K ﹤0.01%
17,296
+1,533
+10% +$37.6K
PSF icon
2500
Cohen & Steers Select Preferred & Income Fund
PSF
$236M
$428K ﹤0.01%
15,076
-297
-2% -$8.21K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.